Composition
- Active ingredients
- LOTEPREDNOL ETABONATE 0.5%
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- LOTEPREDNOL ETABONATE 0.5% · Suspension/dropsNDA020583-001 · Prescription
- LOTEPREDNOL ETABONATE 0.5% · OintmentNDA200738-001 · Prescription
- LOTEPREDNOL ETABONATE 0.5% · Suspension/dropsThis page
- LOTEPREDNOL ETABONATE 0.5% · GelNDA202872-001 · Prescription
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA020841.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Lotemax
- Active substance
- loteprednol etabonate
- Route
- Eye
- Dosage form
- Suspension/drops
- Applicant
- Pharmos
- Status
- Discontinued
- FDA approval
- 9 Mar 1998
- Application
- NDA020841-001